Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adropin is a 76-amino acid peptide hormone encoded by the energy homeostasis-associated gene (ENHO). It is primarily secreted by the liver and plays a crucial role in regulating metabolic homeostasis, cardiovascular function, immune regulation, and neurological function. Its expression is influenced by dietary intake and is associated with various clinical conditions, making it a promising target for therapeutic interventions.
Adropin functions through multiple signaling pathways including the VEGFR2/PI3K/AKT, VEGFR2/ERK1/2, ROCK/MLC2, JAK2/STAT3, and AMPK pathways to regulate various physiological processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adropin (ENHO).